G1 Therapeutics, Inc.
GTHX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5 | -$10 | -$11 | -$18 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $10 | -$10 |
| Stock-Based Comp. | $2 | $3 | $3 | $4 |
| Change in WC | -$3 | -$1 | -$5 | $4 |
| Other Non-Cash | $5 | $1 | -$10 | $9 |
| Operating Cash Flow | -$5 | -$9 | -$13 | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$36 | -$17 | -$47 | -$12 |
| Inv. Sales/Matur. | $37 | $23 | $40 | $20 |
| Other Inv. Act. | $0 | $0 | -$8 | $7 |
| Investing Cash Flow | $0 | $5 | -$8 | $7 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1 | -$9 | $0 | -$2 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | -$0 | $2 |
| Financing Cash Flow | $0 | -$9 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5 | -$12 | -$20 | -$3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20 | $32 | $53 | $56 |
| End Cash | $15 | $20 | $32 | $53 |
| Free Cash Flow | -$5 | -$9 | -$13 | -$11 |